28.02.2008 22:50:00
|
Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors
ST. LOUIS, Feb. 28 /PRNewswire-FirstCall/ -- The Board of Directors of Belden has appointed Mary S. McLeod as a Director and member of the Compensation Committee of the board. Ms. McLeod, age 51, is Senior Vice President of Worldwide Human Resources at Pfizer Inc., a post she has held since April 2007. Pfizer is the world's largest global research-based pharmaceutical company. Prior to joining Pfizer, Ms. McLeod was an executive vice president of Korn Consulting Group, a firm specializing in helping companies through large-scale change. Before joining Korn, she led Human Resources for Symbol Technologies and was the head of Human Resources for Charles Schwab, where she was also Chief of Staff for Schwab's chief executive. In addition, she has worked for Cisco Systems and GE. Ms. McLeod has a bachelor's degree from Loyola University and a master's degree from the University of Missouri.
John Stroup, President and Chief Executive Officer of Belden, said, "We are delighted to welcome Mary McLeod to Belden's Board of Directors and the Compensation Committee of the board. She brings valuable experience helping companies achieve their strategic objectives through effective organizational design and compensation systems."
About Belden
Belden is a leader in the design, manufacture, and marketing of signal transmission solutions for data networking and a wide range of specialty electronics markets including entertainment, industrial, security and aerospace applications. To obtain additional information contact Investor Relations at 314-854-8054, or visit our website at http://www.belden.com/.
From: Belden Dee Johnson Director, Investor Relations and Corporate Communications 314.854.8054
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Belden CDT Inc.mehr Nachrichten
30.10.24 |
Ausblick: Belden CDT verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
31.07.24 |
Ausblick: Belden CDT verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Belden CDT Inc.mehr Analysen
Aktien in diesem Artikel
Belden CDT Inc. | 115,00 | -1,71% | |
Pfizer Inc. | 24,33 | -1,00% |
Indizes in diesem Artikel
Dow Jones | 44 705,53 | -0,17% | |
S&P 500 | 6 049,88 | 0,05% | |
S&P 600 SmallCap | 935,46 | -0,94% | |
S&P 100 | 2 923,16 | 0,22% | |
NYSE US 100 | 17 412,16 | 0,21% |